BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 16, 2004
View Archived Issues
Leptin may regulate energy balance by posttranslational modulation of the melanocortin pathway
Read More
Antiparasitic drug effective against SARS in vitro
Read More
Array BioPharma and QLT collaborate in cancer therapeutics discovery
Read More
Caprion awarded NIAID grant for biodefense research
Read More
Acuity files IND for phase I trials of Cand5
Read More
Novel promising agent for inflammatory bowel disease and glomerulonephritis therapy
Read More
Baxter signs as contract manufacturer for Morphotek's MORAb-003
Read More
GB Therapeutics acquires license for Chiesi's NMDA antagonist
Read More
European orphan drug designation for TheraCIM hR3
Read More
A role for doxycycline in cardioprotection
Read More
Geranylgeranylacetone effective against coronary dysfunction in vivo
Read More
Mechanisms of melatonin cardioprotection
Read More
Pharmacia presents new CDK inhibitors
Read More
Novel factor Xa and/or factor VIIa inhibitors under study at Aventis
Read More
Teijin claims new vitamin D3 analogues for osteoporosis and other disorders
Read More
Ajinomoto presents new prodrugs of factor Xa inhibitors
Read More
New aminobenzophenone prodrugs and their use in skin inflammatory disorders
Read More
New immunosuppressants in early development at Sumitomo
Read More
Novel PPARdelta agonists and their use in diabetes, dyslipidemia, etc.
Read More
Encouraging topline data from phase II ramoplanin study
Read More
Zimycan meets endpoints in phase III study for Candida diaper dermatitis
Read More
BioDelivery Sciences to acquire Arius Pharmaceuticals
Read More
TheraQuest meets with U.S., U.K., Canadian authorities regarding TQ-1011
Read More
Evotec OAI and Seikagaku collaborate in inflammatory disease
Read More
Novartis exercises option to Vernalis' lead Hsp90 oncology program
Read More
Prous Science Award supports research in the field of microwave-assisted chemistry
Read More